Cypress Capital Management LLC Amgen Inc Transaction History

Cypress Capital Management LLC

$0
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $301,000 - $339,474	1,341 Added 54.14%	3,818 $861,000
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $10,381 - $11,553	-45 Reduced 1.78%	2,477 $603,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $18,637 - $20,618	-85 Reduced 3.26%	2,522 $610,000
Q4 2021 Feb 22, 2022	SELL	$198.88 - $227.6 $19,689 - $22,532	-99 Reduced 3.66%	2,607 $586,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $64,234 - $71,263	-275 Reduced 9.23%	2,706 $660,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $27,738 - $32,325	-125 Reduced 4.02%	2,981 $742,000
Q1 2020 Apr 24, 2020	SELL	$182.24 - $241.7 $9,112 - $12,085	-50 Reduced 1.58%	3,106 $630,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $9,460 - $12,160	-50 Reduced 1.56%	3,156 $761,000
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $558,196 - $668,835	3,206 New	3,206 $620,000
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $39,007 - $45,725	-234 Reduced 6.79%	3,211 $592,000
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $535,273 - $627,461	-3,211 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $154,643 - $174,317	-855 Reduced 19.88%	3,445 $654,000
Q4 2018 Feb 05, 2019	BUY	$178.4 - $208.25 $6,244 - $7,288	35 Added 0.82%	4,300 $837,000
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $28,719 - $32,377	-155 Reduced 3.51%	4,265 $884,000
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $16,605 - $18,651	100 Added 2.31%	4,420 $816,000
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $195,691 - $228,690	-1,155 Reduced 21.1%	4,320 $736,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $7,595 - $8,486	45 Added 0.83%	5,475 $952,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $14,219 - $16,235	85 Added 1.59%	5,430 $1.01 Million
Q2 2017 Aug 15, 2017	BUY	N/A	5,345	5,345 $921,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC with notifications on news.

Account